Page last updated: 2024-09-04

sclareol and Cirrhosis

sclareol has been researched along with Cirrhosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Han, X; Liang, G; Ren, J; Shi, Q; Tu, Y; Wang, Y; Wei, J; Ying, H; Zhang, J; Zhang, Y; Zhou, L1
Liang, G; Luo, W; Shan, P; Wang, M; Wang, Y; Wu, G; Xu, D; Yang, N; Zou, C1
Bao, YY; Ge, MX; He, HW; Lu, ZN; Niu, WX1

Other Studies

3 other study(ies) available for sclareol and Cirrhosis

ArticleYear
Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK/NF-κB signaling pathway.
    Phytotherapy research : PTR, 2022, Volume: 36, Issue:6

    Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diterpenes; Fibrosis; Glucose; Hyperglycemia; Inflammation; Kidney; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Signal Transduction

2022
Sclareol attenuates angiotensin II-induced cardiac remodeling and inflammation via inhibiting MAPK signaling.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:2

    Topics: Angiotensin II; Animals; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Myocardium; Myocytes, Cardiac; Ventricular Remodeling

2023
Sclareol attenuates liver fibrosis through SENP1-mediated VEGFR2 SUMOylation and inhibition of downstream STAT3 signaling.
    Phytotherapy research : PTR, 2023, Volume: 37, Issue:9

    Topics: Animals; Fibrosis; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Mice; Rats; Signal Transduction; Sumoylation

2023